140 likes | 165 Views
Read here the market research report on u201cEphedrine Marketu201d published by CMI team.
E N D
Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
Ephedrine Market Analysis (2020-2027) • Ephedrine is a decongestant and bronchodilator, used to treat bronchospasms caused due to asthma. The medicine reduces the swelling and constricts the blood vessels in the nasal passages which widens the lung airways and allows the patient to breathe easily. • Due to the medicine’s central nervous system stimulatory effects, ephedrine is also used extensively during spinal anesthesia in order to prevent intra-operative hypotension. The medicine is available in the form of tablets, capsules and injections.
Global Ephedrine Market – Dynamics • High prevalence of hypotension during spinal anesthesia is expected to propel growth of the ephedrine market over the forecast period. For instance, according to the Columbian Journal of Anesthesiology, 2018, incidences of hypotension during spinal anesthesia ranges from 1.9% to 71% globally. • Moreover, launches and approvals of ephedrine products is expected to boost the ephedrine market growth over the forecast period. For instance, in January 2017, Par Pharmaceutical, a subsidiary of Endo International plc, received approval from the U.S. Food and Drug Administration (FDA) for its new ephedrine sulfate injection, CORPHEDRA. The injection will be used to for the treatment of hypotension occurring in the process of spinal anesthesia.
s • However, restrictions on ephedrine usage through regulatory authorities is expected to restrain the market over the forecast period. For instance, since 2001, the Government of Canada has authorized ephedrine only as a nasal decongestant with a maximum dosage of 8mg along with 32mg in a 24 hour period.
Global Ephedrine Market – Regional Insights • North America accounted for the largest market share in 2018, owing to launches and approvals of new ephedrine products in the region. For instance, in March 2017, Akorn, Inc., a developer and manufacturer of generics and branded prescription pharmaceuticals, received the U.S. Food and Drug Administration (FDA) approval for its New Drug Application (NDA) for single dose ampule of an ephedrine sulfate injection which is indicated for treating hypotension occurring during spinal anesthesia. • Increasing ephedrine product launches is expected to propel the market growth in the Europe region. For instance, in April 2016, Avadel Pharmaceuticals, formerly known as Flamel Technologies, received approval from the U.S. Food and Drug Administration for Akovaz, an ephedrine sulfate injection, which will be used to treat hypotension occurring during anesthesia.
s • Moreover, high prevalence of hypotension during spinal anesthesia in Asia Pacific is likely to drive the ephedrine market over the forecast period. For instance, according to a study published in the Indian Journal of Anesthesia, 2018, the cases of mild, moderate, and severe spinal anesthesia induced hypotension was approximately 20%, 35%, and 40% respectively.
Global Ephedrine Market – Competitive Landscape • Key player operating in the market include Servier, Merck Sharp & Dohme Corp., Amgen Inc., Sanofi S.A., Avadel Pharmaceuticals, GlaxoSmithKline plc, Endo Pharmaceuticals plc, and Akorn Inc.
Global Ephedrine Market – Taxonomy • On the basis of dosage form, the global ephedrine market is segmented into: • Tablets • Capsules • Injections
On the basis of disease indication, the global ephedrine hormonesmarket is segmented into: • Bronchial Asthma • Spinal Anesthesia induced Hypotension • Others • On the basis of distribution channel, the global ephedrine hormonesmarket is segmented into: • Hospitals Pharmacies • Retail Pharmacies • Others • On the basis of region, the global ephedrine hormonesmarket is segmented into: • North America • Latin America • Europe
Asia Pacific • Middle East
Request sample copy here • Request PDF brochure here • Request Customization here • Talk to Analyst • Buy Now • Reference: https://www.coherentmarketinsights.com/ongoing-insight/ephedrine-market-3320
About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/